# Conscience VC

> Conscience VC is a VC fund backing Biotechnology and Health Care. See 15 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Los Angeles, United States
- Total investments: 15
- Last investment: Dec 2024
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/conscience-vc/
- Website: https://conscience.vc/

Conscience VC is a VC fund in Los Angeles focused on Biotechnology and Health Care. Conscience is a venture capital firm that focuses on investing in early-stage consumer and science-led startups embracing deep tech and data sectors.

## Contacts

5 contacts available for Conscience VC. Shizune tracks 17 team members at Conscience VC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/conscience-vc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 8 | 53% |
| Health Care | 6 | 40% |
| Medical | 2 | 13% |
| Genetics | 2 | 13% |
| Wellness | 2 | 13% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 8 | 53% |
| Seed | 6 | 40% |
| Series A | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 12 | 80% |
| Canada | 1 | 7% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| John Williamson | Retired CEO | 0 | https://shizune.co/investors/profile/john-williamson-2 |
| Shawn Seyk | CEO | 0 | https://shizune.co/investors/profile/shawn-seyk |
| Abi King | Yoga Teacher | 0 | https://shizune.co/investors/profile/abi-king-aba2 |
| Beth McDougall | Physician | 0 | https://shizune.co/investors/profile/beth-mcdougall-0255 |
| Billy McDowell | Songwriter | 0 | https://shizune.co/investors/profile/billy-mcdowell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MoldCo | MoldCo helps individuals to reclaim their health from mold. | $3M | Pre-Seed | Dec 10, 2024 |  |
| Integrated Biosciences | Integrated Biosciences is the first company in history to be able to virtually stress cells. | $17.2M | Seed | Oct 03, 2024 |  |
| Cellular Intelligence | Somite is a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies. | $10.3M | Pre-Seed | Apr 10, 2024 |  |
| Portal | Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings. | $5M | Pre-Seed | Mar 19, 2024 |  |
| Tiny Health | Tiny Health is the leading microbiome health platform for people tackling chronic conditions or looking to optimize overall health. Tiny Health’s Gut Health Test is the first-ever at-home gut microbiome test for pregnant moms and babies to use shotgun metagenomics, and the company now also offers tests for older children and adults, as well asVaginal Health Tests.To date, 30,000 families have trusted Tiny Health to correct imbalances in the gut and vaginal microbiome, and optimize their lifelong health. By taking evidence-based action steps from a dietary, supplement and lifestyle based on personalized results, we've helped people reduce severe symptoms and in some cases even reverse chronic conditions. Tiny Health's team includes top scientists, physicians, and microbiologists from Mayo Clinic, Johns Hopkins, Stanford, WashU, Cornell, and Harvard Medical School. For more information, visit tinyhealth.com and poweredbytiny.com | $8.5M | Series A | Mar 05, 2024 |  |
| Aperture Therapeutics | Aperture Therapeutics is a biotechnology company focused on the development of novel therapies for age-related neurodegenerative diseases. Utilizing a unique drug discovery platform, the company aims to harness the genetic diversity of patients to identify new disease pathways and drug targets. With operations based in a lab incubator, ApertureTherapeutics is in the pre-clinical stage, actively applying insights from neuroscience and immunology to advance its research. The company's approach emphasizes the importance of genetic diversity in the discovery process, aiming to lead to more effective treatments for neurodegeneration and neuroimmunology conditions. |  | Pre-Seed | Feb 01, 2024 |  |
| KiraGen Bio | KiraGen Bio is leveraging AI-driven, combinatorial gene editing to unlock the full potential of CAR-T cells against solid tumors. |  | Pre-Seed | Nov 27, 2023 |  |
| Wayfinder Biosciences | Wayfinder Biosciences is a biotechnology company developing orally available small molecule drugs that modulate the function of the RNAs encoding key disease targets. The company's proprietary platform combines unique screening and computational technologies to rapidly discover potent, selective and biologically active RNA-targeting smallmolecules. Wayfinder's programs are focused on traditionally inaccessible targets in oncology and neurodegenerative disease. Wayfinder Biosciences was established in 2021 and is headquartered in Seattle, WA. | $3.6M | Seed | Oct 17, 2022 |  |
| Harmony Baby Nutrition | Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA. | $874K | Seed | Nov 10, 2021 |  |
| Harmony Baby Nutrition | Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA. | $1.2M | Pre-Seed | Nov 10, 2021 |  |

10 of 15 investments shown.

## Co-investors
- [TheVentureCity](https://shizune.co/investors/profile/the-venture-city) — VC Fund, 5 deals together
- [Big Idea Ventures](https://shizune.co/investors/profile/big-idea-ventures) — VC Fund, 3 deals together
- [Divergent Capital](https://shizune.co/investors/profile/divergent-capital-1c5e) — VC Fund, 3 deals together
- [TheVentureCity](https://shizune.co/investors/profile/theventurecity-growth-accelerator) — VC Fund, 3 deals together
- [Mission BioCapital](https://shizune.co/investors/profile/bioinnovation-capital) — VC Fund, 2 deals together
- [K3 Ventures](https://shizune.co/investors/profile/k3-ventures) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does Conscience VC invest in?

Conscience VC invests primarily in Biotechnology, Health Care and Medical startups, most often at Pre-Seed and Seed stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Conscience VC?

Public channels for Conscience VC include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Conscience VC?

The team at Conscience VC includes John Williamson (Retired CEO), Shawn Seyk (CEO) and Abi King (Yoga Teacher), among 17 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co